These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
491 related articles for article (PubMed ID: 8403288)
21. [Lipid risk factors of coronary heart disease during longterm observation of a Warsaw Pol-Monica population-based cohort]. Chotkowska E; Jasiński B; Kupść W; Broda G Pol Arch Med Wewn; 1997 Jan; 97(1):37-46. PubMed ID: 9235550 [TBL] [Abstract][Full Text] [Related]
22. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Koskinen P; Mänttäri M; Manninen V; Huttunen JK; Heinonen OP; Frick MH Diabetes Care; 1992 Jul; 15(7):820-5. PubMed ID: 1516498 [TBL] [Abstract][Full Text] [Related]
24. Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study. Nejat A; Mirbolouk M; Mohebi R; Hasheminia M; Tohidi M; Saadat N; Azizi F; Hadaegh F Clin Biochem; 2014 Sep; 47(13-14):1239-44. PubMed ID: 24657509 [TBL] [Abstract][Full Text] [Related]
25. Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects. Laakso M; Pyörälä K; Voutilainen E; Marniemi J Am J Epidemiol; 1987 Apr; 125(4):611-21. PubMed ID: 3548333 [TBL] [Abstract][Full Text] [Related]
26. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Kannel WB Am Heart J; 1985 Nov; 110(5):1100-7. PubMed ID: 4061265 [TBL] [Abstract][Full Text] [Related]
27. Cholesterol Levels of Six Fractionated Serum Lipoproteins and its Relevance to Coronary Heart Disease Risk Scores. Manita D; Yoshida H; Hirowatari Y J Atheroscler Thromb; 2017 Sep; 24(9):928-939. PubMed ID: 28025448 [TBL] [Abstract][Full Text] [Related]
28. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease. Kesavulu MM; Rao BK; Giri R; Vijaya J; Subramanyam G; Apparao C Diabetes Res Clin Pract; 2001 Jul; 53(1):33-9. PubMed ID: 11378211 [TBL] [Abstract][Full Text] [Related]
29. [Coronary atherosclerosis and serum lipoproteins]. Pometta D; Micheli H Schweiz Med Wochenschr; 1979 Dec; 109(48):1926-30. PubMed ID: 231822 [TBL] [Abstract][Full Text] [Related]
30. Familial aggregation of non-insulin dependent diabetes and coronary heart disease are accompanied by different effects on serum lipids, lipoproteins and apolipoproteins. Sarlund H; Laakso M; Voutilainen E; Penttilä I; Pyörälä K Atherosclerosis; 1991 Jan; 86(1):17-29. PubMed ID: 2064632 [TBL] [Abstract][Full Text] [Related]
31. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Kesavulu MM; Giri R; Kameswara Rao B; Apparao C Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018 [TBL] [Abstract][Full Text] [Related]
32. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Liu J; Sempos C; Donahue RP; Dorn J; Trevisan M; Grundy SM Diabetes Care; 2005 Aug; 28(8):1916-21. PubMed ID: 16043732 [TBL] [Abstract][Full Text] [Related]
34. Fractional esterification rate of HDL particles in patients with type 2 diabetes. Relation to coronary heart disease risk factors. Tan MH; Loh KC; Dobiasova M; Frohlich JJ Diabetes Care; 1998 Jan; 21(1):139-42. PubMed ID: 9538985 [TBL] [Abstract][Full Text] [Related]
35. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Liu J; Sempos CT; Donahue RP; Dorn J; Trevisan M; Grundy SM Am J Cardiol; 2006 Nov; 98(10):1363-8. PubMed ID: 17134630 [TBL] [Abstract][Full Text] [Related]
36. High lipid levels and coronary disease in women in Göteborg--outcome and secular trends: a prospective 19 year follow-up in the BEDA*study. Johansson S; Wilhelmsen L; Lappas G; Rosengren A Eur Heart J; 2003 Apr; 24(8):704-16. PubMed ID: 12713765 [TBL] [Abstract][Full Text] [Related]
37. Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men. Haffner SM; Miettinen H; Stern MP Diabetologia; 1997 Jun; 40(6):711-7. PubMed ID: 9222652 [TBL] [Abstract][Full Text] [Related]
38. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes. Schulze MB; Shai I; Manson JE; Li T; Rifai N; Jiang R; Hu FB Diabetologia; 2004 Dec; 47(12):2129-36. PubMed ID: 15662553 [TBL] [Abstract][Full Text] [Related]
39. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations. Falko JM; Parr JH; Simpson RN; Wynn V Am J Med; 1987 Oct; 83(4):641-7. PubMed ID: 3674053 [TBL] [Abstract][Full Text] [Related]
40. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis. Ahmed HM; Miller M; Nasir K; McEvoy JW; Herrington D; Blumenthal RS; Blaha MJ Am J Epidemiol; 2016 May; 183(10):875-83. PubMed ID: 27189327 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]